SerpentinaDB: a database of plant-derived molecules of Rauvolfia serpentina by Shivalika Pathania et al.
DATABASE Open Access
SerpentinaDB: a database of plant-derived
molecules of Rauvolfia serpentina
Shivalika Pathania1, Sai Mukund Ramakrishnan2, Vinay Randhawa1,3 and Ganesh Bagler1,2,3*
Abstract
Background: Plant-derived molecules (PDMs) are known to be a rich source of diverse scaffolds that could serve as
a basis for rational drug design. Structured compilation of phytochemicals from traditional medicinal plants can
facilitate prospection for novel PDMs and their analogs as therapeutic agents. Rauvolfia serpentina is an important
medicinal plant, endemic to Himalayan mountain ranges of Indian subcontinent, reported to be of immense
therapeutic value against various diseases.
Description: We present SerpentinaDB, a structured compilation of 147 R. serpentina PDMs, inclusive of their plant
part source, chemical classification, IUPAC, SMILES, physicochemical properties, and 3D chemical structures with
associated references. It also provides refined search option for identification of analogs of natural molecules against
ZINC database at user-defined cut-off.
Conclusion: SerpentinaDB is an exhaustive resource of R. serpentina molecules facilitating prospection for
therapeutic molecules from a medicinally important source of natural products. It also provides refined search option
to explore the neighborhood of chemical space against ZINC database to identify analogs of natural molecules
obtained as leads. In a previous study, we have demonstrated the utility of this resource by identifying novel aldose
reductase inhibitors towards intervention of complications of diabetes.
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Background
Plants have evolved to produce a diverse repertoire of
secondary metabolites which have been used as a source
of remedial agents [1, 2]. Medicinal plant extracts have
been known for their efficacy against various diseases,
and are classically used to discover drug-like molecules.
Phytomedicines continue to play a central role in the
health management systems in developing countries
which include 65 % of Indian population. Recent World
Health Organization (WHO) review estimates that
almost 80 % of world’s population depends on traditional
medicines [3]. These indicators have impelled WHO to
incorporate phytomedicines in health care systems.
PDMs have also been recognized to provide specific
substructures or scaffolds that make them comparable
to trade drugs and their potential utilization in combina-
torial chemistry [4].
Therefore, there is ample scope for rationalizing the
process of drug discovery by prospecting for plant-derived
molecules (PDMs) with virtual screening approach. PDMs
could be effectively used to systematically extract unique
molecular scaffolds, which could further be chemically
elaborated to generate novel leads and to screen molecules
from drug-like libraries [5, 6]. Computational approaches,
such as molecular docking, ligand-based virtual screening,
and molecular dynamics (MD), have been widely used in
modern drug discovery to explore drug-receptor interac-
tions, and have been able to restrain the number of PDMs
that confront experimental validation that ultimately
reducing the cost of drug development [1, 7–9]. Thus,
hypothesis driven implementation of such pharmaco-
informatics pipeline hastens the rate of drug discovery of
natural molecules and their simpler mimetics with better
pharmacological properties.
Rauvolfia serpentina is an important medicinal plant
endemic to the Himalayan mountain range of Indian
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subcontinent and South-East Asian countries [10]. Plant
extracts of R. serpentina have been reported to be of
therapeutic value against various diseases (Table 1)
including hypertension, intestinal disorders, eye diseases,
cuts, wounds, splenic diseases, uterine contraction, head-
ache, and skin diseases [11]. Its extracts have also been
reported with a broad range of therapeutic effects such
as antioxidant, antiaging, antihypertensive, anticancerous,
antimalarial, antiinflammatory, antifibrillar, anthelmintic,
antiarrhythmic, anticholinergic, antidysentry, antidiarrhoeal,
antihypotensive, anticontractile, antipyretic, antidiuretic,
sympathomimetic, and antipsychotic [10–12]. Knowing the
potential efficacy of R. serpentina PDMs and their deriva-
tives, its phytochemical space could be effectively explored
for systematical extraction of unique molecular scaffolds
and their derivatives [6]. This strategy has been
followed to identify ‘2 PDM leads’ and their 16 struc-
tural analogs as potent aldose reductase inhibitors
(Additional file 1) [6].
With the aim of providing a comprehensive resource
for rational prospection of R. serpentina PDMs towards
drug discovery, we compiled an extensive, structured
database of its molecules. After a thorough literature
survey, details of PDMs were manually compiled and
curated. We present a database, SerpentinaDB (Fig. 1),
which is structured to include plant part source,
chemical name, chemical class, IUPAC (International
Union of Pure and Applied Chemistry) names, SMILES
(Simplified Molecular-Input Line-Entry System) nota-
tions, and 3D (3-Dimensional) structures for 147 PDMs
with all associated references (Additional file 2). These
3D structures are present in the form of mol2 file format
that is amenable for conversion into other file formats
that are accepted by various drug discovery softwares.
It also provides several physicochemical descriptors of
these PDMs which are indicators of their drug-like
properties. Hence access to repertoire of PDMs like
SerpentinaDB can be of considerable advantage to academia
as well as industry.
Construction and content
Data collation and assembly
In order to build an extensive repository of PDMs from
R. serpentina, data were compiled from literature and
web resources. All resources were manually curated to
extract PDMs data and their additional details including
plant part, chemical name, chemical class, and IUPAC name.
To address degeneracy in the name of the plant, PubMed
(http://www.ncbi.nlm.nih.gov/pubmed) was searched with
two variants of spelling (‘Rauvolfia serpentina’ and ‘Rauwolfia
serpentina’) to obtain relevant information. A total of 31
research articles, 3 books, 2 PhD dissertations[13, 14], and
3 web resources involving natural compounds research
were utilized to compile an extensive list of PDMs. Books
and web resources used for curation of dataincluded
following sources: ‘The Alkaloids’ [15], ‘The Alkaloids:
Chemistry and Physiology’ [16], ‘The Alkaloids: Chemistry
and Physiology’ [17], A database on antidiabetic plants
[18], Global Information Hub On Integrated Medicine
[19], and India Herbs [20]. To authenticate the chemical
details obtained, molecules were also ascertained from
the Dictionary of Natural Products (DNP) [21], PubChem
(https://pubchem.ncbi.nlm.nih.gov/) [22], ChemSpider (http://
www.chemspider.com/) [23], and ChEMBL (https://www.
ebi.ac.uk/chembl/) [24]. 3D chemical structures of mole-
cules were drawn and edited using MarvinSketchv5.10.0
Table 1 Therapeutic properties of Rauvolfia serpentina extracts reported for various diseases. Disease details include simple name of
the disease and its broad classification. Citations for disease associations are provided in Additional file 2
S. No. Disease name Disease type S. No. Disease name Disease type
1 Cancer Immunological 15 Pneumonia Pathological
2 Leukemia Immunological 16 Asthma Immunological
3 AIDS Immunological 17 Rheumatism Immunological
4 Diabetes mellitus Digestive 18 Anasarca Epidermal
5 Hypolipidemia Digestive 19 Helminthiasis Pathological: Parasitic
6 Alzheimer’s disease Neurological 20 Cholera Pathological: Bacterial
7 Schizophrenia Neurological 21 Cardiac arrhythmia Circulatory
8 Skin cancer Immunological 22 Diarrhea Pathological
9 Prostate cancer Immunological 23 Tachycardia Circulatory
10 Hypertension Circulatory 24 Supraventricular tachysystole Circulatory
11 Fever Infectious 25 Thyrotoxicosis Immunological
12 Insect bite Infectious 26 Allergy Immunological
13 Dysentery Digestive 27 Meningitis Pathological
14 Malaria Pathological: Parasitic 28 Encephalitic psychosis Pathological
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software (https://www.chemaxon.com), and further saved into
mol2 file format. These files were subjected to energy
minimization with Merck Molecular Force Field (MMFF94)
using OpenBabel v2.3.1 software [25]. Mol2 format is
desirable due to ease of conversion into other molecular
formats accepted by drug discovery softwares. To remove
redundant entries, data from all resources were merged, and
an extensive library of PDMs was compiled. A total of
147 molecules, reported to be extracted from various plant
parts, were present in final dataset (Fig. 2a) and broadly
classified into different chemical classes (Fig. 2b). Represen-
tative PDM of each of seven chemical classes is provided
in the supplementary file (Additional file 3). A separate
entry was created for molecules that were obtained from
more than one plant part leading to 227 such individual
entries. Of all these PDMs, mol2 files for 5 of them could
not be obtained due to unavailability of both structure as
well as IUPAC. Physicochemical properties of the PDMs,
such energy, atomic contribution to the partition coefficient
(AlogP), distribution coefficient (logD), molecular formula,
molecular mass, molecular solubility, and molecular weight
(MW), acid dissolution constant (pKa), number of aromatic
bonds, number of aromatic rings, and radius of gyration,
hydrogen bond acceptor (HBA) count, hydrogen bond
donor (HBD) count, number of H acceptor, number of H
donor, number of H acceptor (Lipinski), number of H donor
(Lipinski), number of H bonds, solvent accessible surface
area (SASA), and surface area as well as ADMET (ADMET
Solubility, ADMET Solubility Level, ADMET BBB, and
ADMET BBB Level) properties, were obtained using mo-
lecular property finder tool under small molecules category
from the Discovery Studio v4.0 (Accelrys, San Diego, USA).
Figure 3 illustrates the statistics of various physicochemical
properties, such as MW (Fig. 3a), HBA as well as HBD
(Fig. 3b), and molecular volume (MV) (Fig. 3c).
Data architecture and Web interface
SerpentinaDB is hosted in a Server at the Indian Institute
of Technology Jodhpur on a Dell Power Edge R910 server
running a Linux operating system (Red Hat version 5.5).
A total of seven data tables were created to house com-
piled data. SerpentinaDB implements MySQL, an object-
relational database management system (RDBMS) for its
backend performance. Web browser interface was created
using HTML, CSS, Ajax, JavaScript, and jQuery, which
connects MySQL terminal using several PHP scripts. A
Fig. 1 Features of SerpentinaDB interface. (a) Demonstration of accessible search options: (1) Plant part, (2) Chemical class as well as plant part,
and (3) Physicochemical properties based search of PDMs. (b) Result of input query with list of associated PDMs: this page further provides
information of IUPAC, SMILES, physicochemical properties, and 3D visualization with associated references. User can download mol2 file and 2D
structure of PDM for given query. (c) Similarity search of selected PDM against ZINC is also available at user-defined percentage
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JMol visualizer (http://www.jmol.org/) and ZINC database
(http://zinc.docking.org/) has been embedded in Graphical
User Interface (GUI) to provide a 3D visualization and percent-
age similarity search against ZINC, respectively, for all PDMs.
The GUI is designed to be user friendly for data query and
extraction, and has been tested in all major browsers (Chrome,
Firefox, Safari, and Internet Explorer) and OS platforms.
Data access
SerpentinaDB can be explored for PDMs in a number of
ways through querying the database with a simple text
search tool that provides various options for searching. There
are three search sections available to the user with several
constraints in each. Search can be performed with (i) plant
part, (ii) chemical class, and (iii) physicochemical properties
(Fig. 1a). Physicochemical properties search option has ad-
vanced search query options for user to select PDMs in a
particular range based on MW, number of HBA, number of
HBD, and number of aromatic rings. The result for given
query is presented in the same page (Fig. 1b) along with
information such as PDM ID, plant part, chemical name,
chemical class, IUPAC names, SMILES notations, and 3D
structure of PDM with associated references. Clicking the
drop down arrow provides details of physicochemical and
ADMET properties. Two separate links to download mol2
file and 2-Dimensional structure of PDM for given query
has been provided. Also, a JMol visualizer (http://
www.jmol.org/) has been embedded in GUI to provide a
3D visualization of PDM which can be further down-
loaded to mol2 file.
Also, each PDM from result page can be searched, to
explore the neighborhood of chemical space, against
ZINC database to identify analogs of natural molecules
at different percentage similarity cut-off (default 90 %).
In order to perform this search ZINC database, a curated
collection of commercially available chemical compounds
[26], is hyperlinked to result page for each PDM separately
to return their structural analogs. During this similarity
Fig. 2 Distribution of R. serpentina plant-derived molecules. (a) Across various plant parts and (b) chemical classes
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Fig. 3 Distribution of molecular descriptors of R. serpentina plant-derived molecules. (a) Molecular weight. (b) Hydrogen bond acceptor and
Hydrogen bond donor. (c) Molecular volume
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search natural molecules are used as scaffolds to search for
similar mimetics which may have equivalent biological
properties. Thus, SerpentinaDB serves as a portal to facili-
tate the use of natural chemical diversity for drug discovery
through prospection of direct novel leads and their analogs.
Utility and discussion
SerpentinaDB provides comprehensive information of
R. serpentina PDMs as a structured and integrated li-
brary. This database was developed to facilitate prospec-
tion of therapeutic molecules from this medicinally
important plant. Existing repositories of natural com-
pounds, such as NPACT [27], SuperNatural [28], Herb
Ingredients’ Targets [29], and CamMedNP [30], focus on
different utilitarian aspects of PDM libraries. While
some of these databases emphasize on a specific disease
or target-compound interactions, others cover plants of
specific geography. SerpentinDB contains natural mole-
cules of R. serpentina which is an important Himalayan
medicinal plant reported for various pharmacological
properties. While the reported efficacy of R. serpentina
extract against hypertension has been explored very well
to identify specific therapeutic PDMs, its potential against
a host of other disorders (Table 1) is hitherto not pinned
down to specific molecules. This database can facilitate
prospection of novel leads for these disorders from the
repertoire of natural molecules.
Natural molecules have been recognized to provide
specific scaffolds that make them comparable to trade
drugs and their potential utilization in combinatorial
chemistry [4]. The MW distribution of PDMs present
in SerpentinaDB has been found to follow Gaussian
Fig. 4 Strategy implemented towards prospecting for novel ARIs from R. serpentina. R. serpentina extracts are reported to be effective
against diabetes and its complications. Aldose reductase controls the rate-limiting step of polyol pathway, and its inhibition is known to
prevent complications of diabetes. Founded in these empirical facts, we proposed a hypothesis connecting effectiveness of molecular
constituents of plant extracts to a regulatory mechanism central to the disorder [6]. Towards our aim of prospecting for novel ARIs, we compiled a
structured library of R. serpentina PDMs, and screened them to obtain ‘best PDMs’ (3). The best PDMs were refined to obtain two ‘PDM leads’ on the
basis of their structural stability. Further, 16 more ‘ZINC leads’ were identified by screening structural analogs of these plant-derived leads, and
representative analogs were assessed for their structural stability. With this prospection study we presented a repertoire of plant-derived indole
alkaloids, and their analogs, as potential AR inhibitors. This study demonstrated the relevance of SerpentinaDB as a structured repertoire of
molecules from R. serpentina towards hypothesis driven exploration
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distribution and peaked in the range of 300-450 Da
(Fig. 3a) which is similar to drug-like molecules of
previously reported libraries of natural products [31].
Significant number of PDMs have HBA in the range of
3–5 with a sharp decline thereafter, as desired from drug-
like molecules (Fig. 3b). Similarly, HBDs of PDMs have a
peak at 2 with a sharp drop for higher values, as desired
(Fig. 3b). SerpentinaDB PDMs have maximum density in
the ‘Lipinski region of interest’ reflecting their drug-like
properties and hence their utility in prospection of novel
leads. The relevance of SerpentinaDB in drug discovery
has been demonstrated with the virtual screening proto-
col, molecular dynamics, and ZINC similarity search for
potential inhibitors of aldose reductase, a target for com-
plications of diabetes [6]. This hypothesis driven prospec-
tion study yielded two indole alkaloids as well as their
structural analogs as potential AR inhibitors (Fig. 4) [6].
This protocol serves as a demonstration of utility of
SerpentinaDB for rational search of therapeutic molecules
and highlights its relevance [32, 33]. Future extensions of
SerpentinaDB may include 3D structure similarity search
and disease associations for each PDM.
Conclusions
SerpentinaDB is an exhaustive resource of R. serpentina
molecules facilitating prospection for therapeutic mole-
cules from a medicinally important source of natural
products. Pharmacoinformatics pipeline involving virtual
screening to perform docking of molecules against disease
specific target to identify inhibitors. Hence, compilation of
such datasets is essential step towards in-silico drug
discovery that hastens the process of prospection of novel
leads from natural repertoire with drug-like properties in
terms of their biological behavior and toxicity.
Availability and requirements
SerpentinaDB is available at http://home.iitj.ac.in/~bagler/
webservers/SerpentinaDB/. Browsers need to be installed
with latest JAVA plugins. For more support please consult
the FAQs section of SerpentinaDB.
Additional files
Additional file 1: Alodse reductase inhibitors (‘2 PDM leads’ and
their ‘16 structure analogs’) obtained using pharmacoinformatics
pipeline in the study performed by Pathania et al., 2013 [6].
Additional file 2: Details of therapeutic properties of
phytochemicals from R. serpentina against various disorders along
with associated references.
Additional file 3: Representative PDMs from each of seven
chemical classes of R. serpentina.
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